These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 10516738)

  • 21. Fixed combination of irbesartan and hydrochlorothiazide in the management of hypertension.
    Bramlage P
    Vasc Health Risk Manag; 2009; 5(1):213-24. PubMed ID: 19436667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of fixed combinations of irbesartan/hydrochlorothiazide in older vs younger patients with hypertension uncontrolled with monotherapy.
    Cushman WC; Neutel JM; Saunders E; Bakris GL; Ferdinand KC; Ofili EO; Sowers JR; Madder R; Weber MA
    Am J Geriatr Cardiol; 2008; 17(1):27-36. PubMed ID: 18174757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of the efficacy and safety of irbesartan/hydrochlorothiazide combination therapy with irbesartan monotherapy in the treatment of moderate or severe hypertension in diabetic and obese hypertensive patients: a post-hoc analysis review.
    Neutel JM
    Postgrad Med; 2011 Jul; 123(4):126-34. PubMed ID: 21680997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and tolerability of losartan versus enalapril alone or in combination with hydrochlorothiazide in patients with essential hypertension.
    Townsend R; Haggert B; Liss C; Edelman JM
    Clin Ther; 1995; 17(5):911-23. PubMed ID: 8595643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of irbesartan/HCTZ combination therapy as initial treatment for rapid control of severe hypertension.
    Neutel JM; Franklin SS; Oparil S; Bhaumik A; Ptaszynska A; Lapuerta P
    J Clin Hypertens (Greenwich); 2006 Dec; 8(12):850-7; quiz 858-9. PubMed ID: 17170610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of losartan/hydrochlorothiazide in patients with severe hypertension.
    Oparil S; Aurup P; Snavely D; Goldberg A
    Am J Cardiol; 2001 Mar; 87(6):721-6. PubMed ID: 11249890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Irbesartan/Hydrochlorothiazide : in moderate to severe hypertension.
    Croxtall JD; Keating GM
    Drugs; 2008; 68(10):1465-72. PubMed ID: 18578561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Once-daily fixed-combination irbesartan 300 mg/ hydrochlorothiazide 25 mg and circadian blood pressure profile in patients with essential hypertension.
    Coca A; Calvo C; Sobrino J; Gómez E; López-Paz JE; Sierra C; Bragulat E; de la Sierra A
    Clin Ther; 2003 Nov; 25(11):2849-64. PubMed ID: 14693309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of initial blood pressure and comorbidity for the efficacy of a fixed combination of an angiotensin receptor blocker and hydrochlorothiazide in clinical practice.
    Schmieder RE; Schwertfeger M; Bramlage P
    Vasc Health Risk Manag; 2009; 5():991-1000. PubMed ID: 19997579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of fixed combinations of irbesartan/hydrochlorothiazide in hypertensive women: the inclusive trial.
    Ofili EO; Cable G; Neutel JM; Saunders E
    J Womens Health (Larchmt); 2008; 17(6):931-8. PubMed ID: 18681815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicenter Randomized Double-Blind Comparison of Nebivolol plus HCTZ and Irbesartan plus HCTZ in the Treatment of Isolated Systolic Hypertension in Elderly Patients: Results of the NEHIS Study.
    Grassi G; Seravalle G; Brambilla G; Dell'Oro R; Trevano FQ; Fici F; van Bortel L; Mancia G
    Adv Ther; 2017 Jan; 33(12):2173-2187. PubMed ID: 27771847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlled trial of losartan given concomitantly with different doses of hydrochlorothiazide in hypertensive patients.
    Ruilope LM; Simpson RL; Toh J; Arcuri KE; Goldberg AI; Sweet CS
    Blood Press; 1996 Jan; 5(1):32-40. PubMed ID: 8777471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ambulatory blood pressure comparison of the anti-hypertensive efficacy of fixed combinations of irbesartan/hydrochlorothiazide and losartan/hydrochlorothiazide in patients with mild-to-moderate hypertension.
    Neutel JM; Smith D
    J Int Med Res; 2005; 33(6):620-31. PubMed ID: 16372579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zofenopril plus hydrochlorothiazide and irbesartan plus hydrochlorothiazide in previously treated and uncontrolled diabetic and non-diabetic essential hypertensive patients.
    Agabiti-Rosei E; Manolis A; Zava D; Omboni S;
    Adv Ther; 2014 Feb; 31(2):217-33. PubMed ID: 24415271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: the MAPAVEL Study (Monitorización Ambulatoria Presión Arterial APROVEL).
    Coca A; Calvo C; García-Puig J; Gil-Extremera B; Aguilera MT; de la Sierra A; Martín-Hidalgo A; Marín R;
    Clin Ther; 2002 Jan; 24(1):126-38. PubMed ID: 11833827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Valsartan/hydrochlorothiazide is effective in hypertensive patients inadequately controlled by valsartan monotherapy.
    Mallion JM; Carretta R; Trenkwalder P; Martinez JF; Tykarski A; Teitelbaum I; Oddou P; Fagan T;
    Blood Press Suppl; 2003 May; 1():36-43. PubMed ID: 12800986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct Renin inhibition with aliskiren in obese patients with arterial hypertension.
    Jordan J; Engeli S; Boye SW; Le Breton S; Keefe DL
    Hypertension; 2007 May; 49(5):1047-55. PubMed ID: 17353513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Candesartan cilexetil in combination with low-dose hydrochlorothiazide is effective in severe hypertension.
    Oparil S
    Am J Cardiol; 1999 Nov; 84(10A):35S-41S. PubMed ID: 10588093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.
    O'Brien E; Barton J; Nussberger J; Mulcahy D; Jensen C; Dicker P; Stanton A
    Hypertension; 2007 Feb; 49(2):276-84. PubMed ID: 17159081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy and safety of low- and high-dose fixed combinations of irbesartan/hydrochlorothiazide in patients with uncontrolled systolic blood pressure on monotherapy: the INCLUSIVE trial.
    Neutel JM; Saunders E; Bakris GL; Cushman WC; Ferdinand KC; Ofili EO; Sowers JR; Weber MA;
    J Clin Hypertens (Greenwich); 2005 Oct; 7(10):578-86. PubMed ID: 16227760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.